Prior to joining NGM, Ms. Siobhan Nolan Mangini: October 31, 2019: President and Chief Financial Officer. SAN FRANCISCO, July 30, 2019 /PRNewswire/ --Castlight Health, Inc. , June 30, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients,. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; andCorporate Highlights. S. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that Siobhan Nolan Mangini, who has served as the company’s Chief Financial Officer (CFO) since July 2020. Rieflin J. See the complete profile on LinkedIn and discover Siobhan’s connections and jobs at similar companies. Directory of sites Login Contact Support. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Castlight Health, Inc. SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 . C. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230. Exhibit 31. 'I’m excited to share that I am stepping into the CEO role at Castlight Health and my long-time colleague and friend, Siobhan Nolan Mangini has been named… | 179 comments on LinkedInSiobhan Nolan Mangini San Francisco, CA. , a. (the “Company”) and Siobhan Nolan. (NGM) (Nasdaq: NGM), a biotechnology company focused on developing transformative therapeutics for patients, today announced the appointment of Siobhan Nolan Mangini as Chief Financial Officer (CFO). -- William J. Woodhouse, Principal Executive Officer of NGM Biopharmaceuticals, Inc. ) 333 Oyster Point BoulevardSIOBHAN NOLAN MANGINI (TREASURER) CASTLIGHT HEALTH, INC. SOUTH SAN FRANCISCO, Calif. SOUTH SAN FRANCISCO, Calif. David J. “The Salt Lake City area provides access to a talented workforce that will enable us to deliver innovative healthcare technology solutions to our customers. Goeddel co-founded Tularik in November 1991, was Vice President of Research until 1996 and Chief Executive Officer from 1996 through 2004. Siobhan Nolan Mangini San Francisco, CA. Siobhan Nolan Mangini San Francisco, CA. 2 . NGM Biopharmaceuticals, Inc. CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO . , May 27, 2020 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. Siobhan Nolan Mangini Chief Financial Officer Senior Management Since: 2020 Age: 42 The latest Tweets from Siobhan Nolan (@SiobhanNolan2). C. Siobhan is responsible for finance, investor relations, accounting, facilities, and business operations. * NGM BIO APPOINTS SIOBHAN NOLAN MANGINI AS CHIEF FINANCIAL OFFICER. to its Board of Directors. C. on Form 10-K for the year ended December 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange. NGM Biopharmaceuticals appoints CFO Siobhan Nolan Mangini to the additional role of President SA News Thu, Jun. , May 27, 2020 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. 150 Spear Street, Suite 400. Ms. SOUTH SAN FRANCISCO, Calif. for-phone-only for-tablet-portrait-up for-tablet. Executive Vice President and Chief. IN CASE YOU MISSED IT - 'Pity city. I'm looking for a finance leader to join me on an exciting journey to create and deliver life changing medicines to patients! Please contact Courtney Grafe if…NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer . CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO . 2 . Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and Enjoy a 7-Day Free Trial Thru Sep 19, 2023! . D. NGM Biopharmaceuticals, +8 more Stanford University Graduate School of Business, +2 more. Hui Tian Senior Vice President Research. We have over 25%, so north of 60 customers that are some level. D. Ms. § 1350), David J. C. Peter Svennilson owns about 971,231 units of Ngm Biopharmaceuticals Inc common. Rishi Jain, lead author on the poster presented at ESMO today w/ initial data from our ongoing Phase 1a/1b study of NGM120, comments on the preliminary. Siobhan Nolan Mangini has served as Chief Financial Officer of Castlight Health, Inc. , Chief Executive Officer, and Siobhan. Siobhan Nolan Mangini is the CFO of NGM Bio (NASDAQ:NGM), a clinical-stage biopharmaceutical company. Siobhan Nolan Mangini San Francisco, CA. Woodhouse, Ph. Before that, she worked as a management consultant. 4. (NYSE:NYSE:CSLT) Q2 2017 Results Earnings Conference Call August 2, 2017 5:00 PM ETExecutivesJohn Doyle - CEOSiobhan Nolan Mangini - CFOAnalystsSamantha Warman -. , Exec. Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U. Back. Select this result to view Siobhan K Nolan's phone number, address, and more. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Castlight Health Inc. Siobhan Nolan Mangini President & Chief Financial Officer. Chief Financial Officer. Most recently she exercised <b>83,925 units of NGM stock worth $407,876 on 16 February 2020</b>. Siobhan Nolan Mangini Published Jan 10, 2020 + Follow After nearly eight years at Castlight, I am stepping back from the most important, challenging, and fulfilling experience of my career. S. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients,. S. Announced that Siobhan Nolan Mangini, who has served as Chief Financial Officer since July 2020, was appointed to the additional role of President of NGM Bio. Chief Financial Officer. , a biotechnology company focused on developing transformative therapeutics for patients, today announced the. , June 30, 2022 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. Back Submit. Siobhan Nolan Mangini: October 31, 2019: President and Chief Financial Officer. MANGINI. Announced that Siobhan Nolan Mangini, who has served as Chief Financial Officer since July 2020, was appointed to the additional role of President of NGM Bio. Siobhan Nolan United States. (d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and Siobhan has a great ability to get people to buy into her vision and beliefs which is essential in her role. THE SARBANES-OXLEY ACT OF 2002 . 30, 2022. Siobhán N. on Form 10-K for the annual period ended December 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities. To support a smooth transition, she will stay on until December 1, 2023. S. . Woodhouse, Ph. Siobhan Nolan Mangini’s Post. Dr. (NYSE: CSLT) today announced that Maeve O'Meara has been named as the company's CEO and to a seat on its Board of Directors, and that Siobhan Nolan Mangini will serve. Economic Impact & Company News Welcoming Siobhan Nolan Mangini: a conversation with Virta’s newest board member Published on April 18, 2023 Virta Health We are excited to welcome the newest addition to the Virta board of directors: Siobhan. Siobhan Nolan Mangini is the current President and Chief Financial Officer of NGM Biopharmaceuticals. , June 30, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. PrestonCastlight Health, Inc. I, Siobhan Nolan Mangini, certify that: Siobhan Nolan Mangini San Francisco, CA. . 32 Questions at NGM Bio: Siobhan Nolan Mangini & David Woodhouse Siobhan Nolan Mangini. NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. Mangini is the former President and CFO of Castlight Health, where she spent eight. Siobhan has 9 jobs listed on their profile. Siobhan Nolan Mangini. Siobhan is related to Sharyn Kristeen Nolan and Emily Cathleen Nolan as well as 3 additional people. Virta Health, +10 more , +2 more Siobhan Nolan Account Executive at Picaso-Halstead Management New York City Metropolitan Area. Siobhan Nolan Mangini - Vice President-Finance & Business Operations. : We ended the quarter with around 250 customers, about over 30% of those Fortune 500. Dear Siobhan, Subject to the approval of the Company’s Board of Directors, you will be awarded 250,000 restricted stock units, to acquire shares of Company Class B Common Stock ("RSUs") under its 2014 Equity Incentive Plan (“Plan”). Siobhan Nolan Mangini San Francisco, CA. S. Siobhan Nolan United States. ,. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that Siobhan Nolan Mangini, who has served as the company’s Chief. 13 others named Siobhan. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; andEnjoy a 7-Day Free Trial Thru Sep 19, 2023! . Most recently she exercised <b>83,925 units of NGM stock worth $424,661 on 16 February 2020</b>. Prior to that, Ms. § 1350), David J. --NGM Biopharmaceuticals, Inc. Most recently she exercised <b>83,925 units of NGM stock worth $421,304 on 16 February 2020</b>. I, Siobhan Nolan Mangini, certify that:SOUTH SAN FRANCISCO, Calif. C. Sign Up. John Doyle is stepping down from his. Siobhan Nolan Ireland. Based on my knowledge, I, Siobhan Nolan Mangini, certify, pursuant to 18 U. Dr. S. The Registered Agent on file for this company is CT Corporation System and is located at 3800 N Central Ave Ste 460, Phoenix, AZ 85012. See the complete profile on LinkedIn and discover Siobhan’s connections and jobs at similar companies. Nolan Mangini served as President and Chief Financial Officer (CFO) of Castlight Health, a publicly traded San Francisco-based healthcare technology company. NGM Biopharmaceuticals, Inc. NGM Biopharmaceuticals, Inc. 12, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. Woodhouse, Ph. She received an MBA from Stanford Graduate School of Business, a graduate degree from Harvard Kennedy School of Government and an undergraduate degree from The Wharton School of the University of Pennsylvania. May 27, 2020, 8:05 PM UTC. Nolan Mangini will oversee finance, business development and investor relations at NGM. Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U. “We are thrilled to welcome Siobhan to. * NGM BIO APPOINTS SIOBHAN NOLAN MANGINI AS CHIEF FINANCIAL OFFICER. , June 30, 2022 -- NGM Biopharmaceuticals, Inc. Most recently she exercised <b>83,925 units of NGM stock worth $182,957 on 16 February 2020</b>. C. Siobhan Nolan Mangini San Francisco, CA. C. Share this article. Siobhan Nolan Mangini is President/CFO at Ngm Biopharmaceuticals Inc. Rieflin to transition from Executive Chairman to Chairman of the Board of Directors --. Share this article. Most recently she exercised <b>83,925 units of NGM stock worth $237,508 on 16 February 2020</b>. , Ste 300, San Francisco, CA 94105. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Most recently, Ms. Founding Partner, CDL-Seattle | Managing Director, Voyager Capital. , June 30, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. , on Equilar ExecAtlas to see current and past work history and gain access to Siobhan Nolan Mangini's network of 29 business contacts. . in her new role Ms. (NYSE: CSLT) today announced that Maeve O’Meara has been named as the company’s CEO and to a seat on its Board of Directors, and that Siobhan Nolan Mangini will serve as the company’s President and retain her position of Chief Financial Officer. Siobhán N. , June 30, 2022 -- NGM Biopharmaceuticals, Inc. Valuable research and technology reports. “We are excited to open Castlight’s Center of Excellence in Utah,” said Siobhan Nolan Mangini, president and CFO of Castlight Health. Nolan Mangini supported the enterprise SAAS company’s growth from a few thousand users to 20 million users and scale up of its customer base, including large. -- William J. Mangini is the former President and CFO of Castlight Health, where she spent eight. Nolan Mangini will oversee finance, business development and investor relations at NGM. C. S. Nolan Mangini served in various roles at Castlight Health, Inc. Castlight Health, Inc. Woodhouse, Chief Executive Officer of NGM Biopharmaceuticals, Inc. NGM Bio Appoints Siobhan Nolan Mangini as Chief Financial Officer. Ms Nolan owns over 83,925 units of Ngm Biopharmaceuticals Inc stock worth over $1,582,542 and over the last 7 years she sold NGM stock worth over $131,848. S. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: Castlight Health, Inc. Dr. Siobhan Nolan Senior Manager, Enterprise Technology Transformation at Deloitte United Kingdom. SmithRx is a transparent, pass-through pharmacy benefits manager for self-insured employers. Siobhan Nolan Mangini is currently associated with two companies, according to public records. , or Castlight, now known as apree health, a healthcare technology company, from 2012 to February 2020, and most recently as President from. 6/30/2022 8:08:48 AM. 2 . In her role as CFO, which will take effect on July 13, 2020, Ms. Ms has made over <b>35 trades</b> of the Ngm Biopharmaceuticals Inc stock since 2016, according to the Form 4 filled with the SEC. In a time with increased market volatility, and compromised stock-based incentive programs, I’m glad to have had the opportunity to see VVA-linked incentive. D. SOUTH SAN FRANCISCO, Calif. Siobhan Nolan Mangini serve as the company’s President and retain her position of Chief Financial Officer. SOUTH SAN FRANCISCO, Calif.